Literature DB >> 12111583

Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification.

Makoto Kubo1, Mitsuru Sasako, Takuji Gotoda, Hiroyuki Ono, Mitsuhiro Fujishiro, Daizo Saito, Takeshi Sano, Hitoshi Katai.   

Abstract

BACKGROUND: In Japan, approximately half of gastric cancers are diagnosed in the early stage. Longer survival has been provided for patients with early gastric cancer (EGC). Several new surgical procedures have been employed for some EGCs. To compare the functional results of these techniques with those of classic distal gastrectomy, it is important to evaluate the remnant stomach in relation to quality of life (QOL) and secondary cancers. We propose a new endoscopic classification, regarding several aspects of the remnant stomach, which enables common understanding and description of the condition.
METHODS: Of 651 patients who underwent a distal gastrectomy or pylorus-preserving gastrectomy (PPG), 324 had at least one upper gastrointestinal (GI) endoscopy during the follow-up period. Ninety-three of the 324 patients underwent a Roux-en-Y reconstruction (RY); 175, Billroth type 1 (B1); and 56, PPG. Endoscopic findings regarding residual food, gastritis, and bile reflux in the gastric stump were investigated for these patients. We classified the amount of residual food into five grades, the degree and the extent of gastritis into five grades, and bile reflux into two grades. First, we evaluated the consistency of diagnosis between two endoscopists, in the first 200 patients, and then we applied the classification to all 324 patients to examine the usefulness of this classification.
RESULTS: Consistency of diagnosis was obtained between two endoscopists who classified the patients independently. The agreement rate was 98.5% for residual food, 93% for gastritis, and 100% for bile reflux. Residual food was observed in 14.0% of the RY group, 22.3% of the B1 group, and 37.5% of the PPG group. These differences were significant (RY versus B1; P < 0.05 and RY versus PPG; P < 0.01). The remnant stomach after B1 showed significantly more severe and extensive gastritis than that after RY and PPG ( P < 0.01). As for bile reflux, there was no significant difference among the three groups.
CONCLUSION: The classification (RGB classification: Residue, Gastritis, Bile) can be used easily and is practical. The results suggest some important differences among methods of reconstruction. This classification seems to be useful to describe these findings and to further evaluate these reconstructive methods.

Entities:  

Mesh:

Year:  2002        PMID: 12111583     DOI: 10.1007/s101200200014

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  73 in total

1.  Functional outcomes according to the size of the gastric remnant and type of reconstruction following laparoscopic distal gastrectomy for gastric cancer.

Authors:  Eiji Nomura; Sang-Woong Lee; George Bouras; Takaya Tokuhara; Michihiro Hayashi; Masako Hiramatsu; Jyunji Okuda; Nobuhiko Tanigawa
Journal:  Gastric Cancer       Date:  2011-04-26       Impact factor: 7.370

2.  What is the best reconstruction method after distal gastrectomy for gastric cancer?

Authors:  Moon-Soo Lee; Sang-Hoon Ahn; Ju-Hee Lee; Do Joong Park; Hyuk-Joon Lee; Hyung-Ho Kim; Han-Kwang Yang; Nayoung Kim; Won Woo Lee
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

3.  Nutritional assessment of patients after pylorus-preserving gastrectomy for early gastric cancer.

Authors:  Masahide Ikeguchi; Hirohiko Kuroda; Kyouichi Kihara; Tomoko Hatata; Tomoyuki Matsunaga; Kenji Fukuda; Hiroaki Saito; Shigeru Tatebe
Journal:  Indian J Surg       Date:  2010-11-17       Impact factor: 0.656

Review 4.  Current status of pylorus-preserving gastrectomy for the treatment of gastric cancer: a questionnaire survey and review of literatures.

Authors:  Chikashi Shibata; Fumito Saijo; Masayuki Kakyo; Makoto Kinouchi; Naoki Tanaka; Iwao Sasaki; Takashi Aikou
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

5.  Correlation between the length of the pyloric cuff and postoperative evaluation after pylorus-preserving gastrectomy.

Authors:  Shinji Morita; Mitsuru Sasako; Makoto Saka; Takeo Fukagawa; Takeshi Sano; Hitoshi Katai
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

6.  Can Proximal Gastrectomy with Double-Tract Reconstruction Replace Total Gastrectomy? A Propensity Score Matching Analysis.

Authors:  Hyo Jung Ko; Ki Hyun Kim; Si-Hak Lee; Cheol Woong Choi; Su Jin Kim; Chang In Choi; Dae-Hwan Kim; Dong-Heon Kim; Sun-Hwi Hwang
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

7.  β-Shaped intracorporeal Roux-en-Y reconstruction after totally laparoscopic distal gastrectomy.

Authors:  Kazuo Motoyama; Kazuyuki Kojima; Mikiko Hayashi; Keiji Kato; Mikito Inokuchi; Kenichi Sugihara
Journal:  Gastric Cancer       Date:  2013-11-01       Impact factor: 7.370

8.  Roux-en-Y reconstruction is superior to billroth I reconstruction in reducing reflux esophagitis after distal gastrectomy: special relationship with the angle of his.

Authors:  Tsutomu Namikawa; Hiroyuki Kitagawa; Takehiro Okabayashi; Takeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

9.  Roux-en-Y reconstruction at greater curvature in biliopancreatic diversion: effects on early postoperative functional recovery.

Authors:  Valerio Ceriani; Tiziana Lodi; Andrea Porta; Oscar Roncaglia; Chiara Osio; Edoardo Faleschini; Paola Bignami; Massimiliano Coladonato; Ahmed Elnabil-Mortada; Annalisa Belloni; Daniela Baldoli; Paolo Gaffuri
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

10.  Long-term outcome after proximal gastrectomy with jejunal interposition for gastric cancer compared with total gastrectomy.

Authors:  Isao Nozaki; Shinji Hato; Takaya Kobatake; Koji Ohta; Yoshirou Kubo; Akira Kurita
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.